<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Cannabics Pharmaceuticals Inc — News on 6ix</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc</link>
<description>Latest news and press releases for Cannabics Pharmaceuticals Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 08 Nov 2022 14:01:41 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/cannabics-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835577978dffbe2df0ea33b.webp</url>
<title>Cannabics Pharmaceuticals Inc</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc</link>
</image>
<item>
<title>CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-to-enter-the-cancer-immunotherapy-market-after-acquiring-a-controlling-interest-in-tageza-biopharma</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-to-enter-the-cancer-immunotherapy-market-after-acquiring-a-controlling-interest-in-tageza-biopharma</guid>
<pubDate>Tue, 08 Nov 2022 14:01:41 GMT</pubDate>
<description>CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma.</description>
</item>
<item>
<title>CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-files-new-pct-patent-application-for-cannabinoids-based-neoadjuvant-cancer-therapy</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-files-new-pct-patent-application-for-cannabinoids-based-neoadjuvant-cancer-therapy</guid>
<pubDate>Tue, 18 Oct 2022 13:11:09 GMT</pubDate>
<description>CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy.</description>
</item>
<item>
<title>CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-patent-application-composition-and-method-for-treating-cancer-with-cannabinoids-enters-national-phase-in-us-and-israel</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-patent-application-composition-and-method-for-treating-cancer-with-cannabinoids-enters-national-phase-in-us-and-israel</guid>
<pubDate>Thu, 13 Oct 2022 12:56:10 GMT</pubDate>
<description>CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel.</description>
</item>
<item>
<title>CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-peer-reviewed-study-possible-future-therapeutic-value-for-cnbx-proprietary-drug-candidate</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-peer-reviewed-study-possible-future-therapeutic-value-for-cnbx-proprietary-drug-candidate</guid>
<pubDate>Thu, 29 Sep 2022 13:11:10 GMT</pubDate>
<description>CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate.</description>
</item>
<item>
<title>CNBX Pharmaceuticals Announces New Patent Granted in Australia</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-pharmaceuticals-announces-new-patent-granted-in-australia</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-pharmaceuticals-announces-new-patent-granted-in-australia</guid>
<pubDate>Wed, 28 Sep 2022 13:27:10 GMT</pubDate>
<description>CNBX Pharmaceuticals Announces New Patent Granted in Australia.</description>
</item>
<item>
<title>CNBX Pharmaceuticals Release a New Corporate Presentation</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-pharmaceuticals-release-a-new-corporate-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-pharmaceuticals-release-a-new-corporate-presentation</guid>
<pubDate>Tue, 31 May 2022 13:21:09 GMT</pubDate>
<description>CNBX Pharmaceuticals Release a New Corporate Presentation.</description>
</item>
<item>
<title>CNBX Pharmaceuticals Granted Patent in Hong Kong</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-pharmaceuticals-granted-patent-in-hong-kong</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-pharmaceuticals-granted-patent-in-hong-kong</guid>
<pubDate>Thu, 05 May 2022 13:12:40 GMT</pubDate>
<description>CNBX Pharmaceuticals Granted Patent in Hong Kong.</description>
</item>
<item>
<title>Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-changes-name-to-cnbx-pharmaceuticals</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-changes-name-to-cnbx-pharmaceuticals</guid>
<pubDate>Mon, 28 Mar 2022 13:01:40 GMT</pubDate>
<description>Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals.</description>
</item>
<item>
<title>CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-selects-api-supplier-purisys-to-support-planned-ind-fillings-and-phase-iii-a-clinical-trials</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-selects-api-supplier-purisys-to-support-planned-ind-fillings-and-phase-iii-a-clinical-trials</guid>
<pubDate>Thu, 04 Nov 2021 12:33:41 GMT</pubDate>
<description>CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials.</description>
</item>
<item>
<title>Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/meet-cnbx-at-radiation-therapy-conference-rtc-2021-in-chicago</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/meet-cnbx-at-radiation-therapy-conference-rtc-2021-in-chicago</guid>
<pubDate>Tue, 26 Oct 2021 13:16:11 GMT</pubDate>
<description>Meet CNBX at Radiation Therapy Conference (RTC) 2021 in Chicago.</description>
</item>
<item>
<title>Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/radiation-oncology-expert-joins-cannabics-pharmaceuticals-board-of-advisors</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/radiation-oncology-expert-joins-cannabics-pharmaceuticals-board-of-advisors</guid>
<pubDate>Mon, 25 Oct 2021 12:56:38 GMT</pubDate>
<description>Radiation Oncology Expert Joins Cannabics Pharmaceuticals' Board of Advisors.</description>
</item>
<item>
<title>EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/edison-publishes-healthcare-quickview-on-cannabics-pharmaceuticals-cnbx</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/edison-publishes-healthcare-quickview-on-cannabics-pharmaceuticals-cnbx</guid>
<pubDate>Thu, 21 Oct 2021 12:34:40 GMT</pubDate>
<description>EDISON Publishes Healthcare QuickView on Cannabics Pharmaceuticals: CNBX.</description>
</item>
<item>
<title>CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-director-dr-inbar-maymon-pomeranchik-to-participate-at-mjbizcon-in-las-vegas</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cnbx-director-dr-inbar-maymon-pomeranchik-to-participate-at-mjbizcon-in-las-vegas</guid>
<pubDate>Wed, 20 Oct 2021 12:36:40 GMT</pubDate>
<description>CNBX Director, Dr. Inbar Maymon-Pomeranchik, to Participate at MJBizCon in Las Vegas.</description>
</item>
<item>
<title>CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/ceo-of-cannabics-pharmaceuticals-eyal-barad-to-present-at-edison-open-forum-cannabinoids-2021</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/ceo-of-cannabics-pharmaceuticals-eyal-barad-to-present-at-edison-open-forum-cannabinoids-2021</guid>
<pubDate>Tue, 19 Oct 2021 13:43:10 GMT</pubDate>
<description>CEO of Cannabics Pharmaceuticals, Eyal Barad, to present at Edison Open Forum: Cannabinoids 2021.</description>
</item>
<item>
<title>Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-files-2-provisional-patents-on-compositions-and-methods-for-treating-cancer</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-files-2-provisional-patents-on-compositions-and-methods-for-treating-cancer</guid>
<pubDate>Mon, 18 Oct 2021 13:06:09 GMT</pubDate>
<description>Cannabics Pharmaceuticals Files 2 Provisional Patents On Compositions and Methods for Treating Cancer.</description>
</item>
<item>
<title>CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/ceo-eyal-barad-and-dr-david-sans-from-cannabics-pharmaceuticals-in-nyc-to-participate-at-benzingas-cannabis-capital-conference</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/ceo-eyal-barad-and-dr-david-sans-from-cannabics-pharmaceuticals-in-nyc-to-participate-at-benzingas-cannabis-capital-conference</guid>
<pubDate>Thu, 14 Oct 2021 13:16:11 GMT</pubDate>
<description>CEO Eyal Barad and Dr. David Sans from Cannabics Pharmaceuticals in NYC, to Participate at Benzinga's Cannabis Capital Conference.</description>
</item>
<item>
<title>Cannabics Announces New Corporate Logo, New Website and New Company Presentation</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-announces-new-corporate-logo-new-website-and-new-company-presentation</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-announces-new-corporate-logo-new-website-and-new-company-presentation</guid>
<pubDate>Thu, 30 Sep 2021 13:26:11 GMT</pubDate>
<description>Cannabics Announces New Corporate Logo, New Website and New Company Presentation.</description>
</item>
<item>
<title>Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/gabriel-yariv-executive-director-of-cannabics-pharmaceuticals-and-dr-david-sans-will-participate-at-the-icdp-summit-in-boston</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/gabriel-yariv-executive-director-of-cannabics-pharmaceuticals-and-dr-david-sans-will-participate-at-the-icdp-summit-in-boston</guid>
<pubDate>Wed, 22 Sep 2021 13:16:10 GMT</pubDate>
<description>Gabriel Yariv, Executive Director of Cannabics Pharmaceuticals and Dr. David Sans will participate at the ICDP Summit in Boston.</description>
</item>
<item>
<title>Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-hires-healthcare-investment-banker-dr-david-sans-in-new-york-to-expand-cnbx-in-mental-health-diseases</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/cannabics-pharmaceuticals-hires-healthcare-investment-banker-dr-david-sans-in-new-york-to-expand-cnbx-in-mental-health-diseases</guid>
<pubDate>Tue, 21 Sep 2021 13:21:10 GMT</pubDate>
<description>Cannabics Pharmaceuticals hires Healthcare Investment Banker Dr. David Sans in New York to expand CNBX in Mental Health Diseases.</description>
</item>
<item>
<title>Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine</title>
<link>https://6ix.com/company/cannabics-pharmaceuticals-inc/news/neuropsychiatry-expert-dr-ilya-reznik-md-joins-cannabics-as-head-of-psychedelic-inspired-medicine</link>
<guid isPermaLink="true">https://6ix.com/company/cannabics-pharmaceuticals-inc/news/neuropsychiatry-expert-dr-ilya-reznik-md-joins-cannabics-as-head-of-psychedelic-inspired-medicine</guid>
<pubDate>Mon, 13 Sep 2021 12:26:09 GMT</pubDate>
<description>Neuropsychiatry Expert Dr. Ilya Reznik (MD) Joins Cannabics as Head of Psychedelic Inspired Medicine.</description>
</item>
</channel>
</rss>